Mosseri Marlio Charles's Form 4 filing
Nuvectis Pharma, Inc. (NVCT) · filed May 9, 2025
- Accession no.
- 0001104659-25-046882
- Filed
- May 9, 2025
- Trade date
- May 6-8, 2025
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 8 non-derivative transactions. Open-market purchases total $235.6K. It was filed 3 days after the trade, past the 2-business-day deadline.
This filing was later replaced by the amendment 0001104659-25-047089 (May 12, 2025). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mosseri Marlio CharlesCIK 0001806384 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 6, 2025 | Common Stock | PPurchaseAcquired | +2,340 | $8.40 | +$19,656 | 2,886,461 | Indirect | |
| May 6, 2025 | Common Stock | PPurchaseAcquired | +10,104 | $8.64 | +$87,298.56 | 2,896,565 | Indirect | |
| May 7, 2025 | Common Stock | PPurchaseAcquired | +2,703 | $8.40 | +$22,705.2 | 2,899,268 | Indirect | |
| May 7, 2025 | Common Stock | PPurchaseAcquired | +9,614 | $8.64 | +$83,064.96 | 2,908,882 | Indirect | |
| May 8, 2025 | Common Stock | PPurchaseAcquired | +50 | $8.65 | +$432.5 | 2,908,932 | Indirect | |
| May 8, 2025 | Common Stock | PPurchaseAcquired | +100 | $8.65 | +$865 | 2,909,032 | Indirect | |
| May 8, 2025 | Common Stock | PPurchaseAcquired | +100 | $8.65 | +$865 | 2,909,132 | Indirect | |
| May 8, 2025 | Common Stock | PPurchaseAcquired | +2,400 | $8.65 | +$20,760 | 2,911,532 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.